inhibitory glp 1 AdipoGen Mechanism of action for GIP,

Whether more negative side effects of allulose ingestion occur when allulose is administered alone and not in the context of other dietary items (food or drinks) that also contain glucose or sucrose needs to be determined

A drug may show strong weight-loss results and still need careful review for heart effects, mood changes, nutrition problems, or long-term risks

Semaglutide 2.4 mg (Wegovy) has shown robust weight loss in primary obesity trials, with mean weight reductions of 14.9% in the STEP 1 trial published in the New England Journal of Medicine (2021)

Providers should reassess B12 blood levels every 3 to 6 months to determine whether continued injections are warranted

Are generic alternatives available for either of these medications

doi: 10.1038/s41419-023-05669-4